Abstract

Indonesia currently has the fastest growing HIV epidemic among Asian countries. Moreover, co-infections with hepatitis B and C virus are not uncommon among HIV infected-patients. Comprehensive information about these co-infections is scarce. In this article, we summarize information of HIV and hepatitis co-infections in Indonesia. The co-infection prevalence as well as the viral genotypic distribution of viral hepatitis is described among HIV-infected individuals. Challenges that exist in diagnosing, treating and monitoring of HIV and viral hepatitis coinfected patients in developing countries are discussed. Further work in providing affordable drugs and cheaper monitoring tools are needed in order to increase the number of co-infected patients receiving treatment.

, ,
C.A.B. Boucher (Charles) , A.J. van der Ven
Erasmus University Rotterdam
The research described in this thesis was conducted at the Viroscience lab of the Erasmus MC, the Netherlands and at the Hasan Sadikin hospital.Financial support for this research was obtained from a Japan International Presidential Scholarship (JIPS) from the World Bank. Financial support for printing of this thesis from Viroclinics Biosciences B.V.
hdl.handle.net/1765/77032
Erasmus MC: University Medical Center Rotterdam

Fibriani, A. (2014, October 17). HIV and hepatitis virus co-infection among injecting drug users in West Java, Indonesia
users in West Java, Indonesia. Retrieved from http://hdl.handle.net/1765/77032